T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HONE
2701
DELISTED
HarborOne Bancorp
HONE
| $166K | ﹤0.01% |
12,733
+208
| +2% | +$2.59K |
|
|
OPTU
2702
Optimum Communications Inc
OPTU
$229M
| $164K | ﹤0.01% |
66,400
| – | – |
|
|
ATXS
2703
DELISTED
Astria Therapeutics
ATXS
| $164K | ﹤0.01% |
14,884
| – | – |
|
2704
UroGen Pharma
URGN
$2.4B
| $164K | ﹤0.01% |
12,839
+1,891
| +17% | +$28.1K |
|
|
CHMI
2705
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $163K | ﹤0.01% |
44,762
| – | – |
|
2706
Savara
SVRA
$1.11B
| $163K | ﹤0.01% |
38,432
+7,448
| +24% | +$32.9K |
|
2707
Erasca
ERAS
$6.39B
| $162K | ﹤0.01% |
59,138
+22,993
| +64% | +$64.8K |
|
2708
Quad
QUAD
$504M
| $162K | ﹤0.01% |
35,617
+2,063
| +6% | +$10.2K |
|
2709
Telos
TLS
$327M
| $162K | ﹤0.01% |
45,042
| – | – |
|
|
AIOT
2710
PowerFleet Inc
AIOT
$416M
| $162K | ﹤0.01% |
32,301
+3,421
| +12% | +$16.2K |
|
|
INVX
2711
Innovex International
INVX
$2.16B
| $162K | ﹤0.01% |
10,971
+186
| +2% | +$2.98K |
|
2712
Aclaris Therapeutics
ACRS
$871M
| $161K | ﹤0.01% |
139,400
| – | – |
|
2713
Precigen
PGEN
$2.37B
| $161K | ﹤0.01% |
169,501
| – | – |
|
2714
Weave Communications
WEAV
$397M
| $161K | ﹤0.01% |
12,513
| – | – |
|
2715
nLIGHT
LASR
$3.01B
| $160K | ﹤0.01% |
14,915
+248
| +2% | +$2.81K |
|
2716
National CineMedia
NCMI
$247M
| $160K | ﹤0.01% |
22,665
| – | – |
|
|
PKST
2717
DELISTED
Peakstone Realty Trust
PKST
| $160K | ﹤0.01% |
11,729
+172
| +1% | +$2.25K |
|
2718
Planet Labs
PL
$8.7B
| $160K | ﹤0.01% |
71,389
+20,711
| +41% | +$46K |
|
|
AMPS
2719
DELISTED
Altus Power
AMPS
| $160K | ﹤0.01% |
50,117
| – | – |
|
2720
Century Casinos
CNTY
$34.6M
| $158K | ﹤0.01% |
61,400
| – | – |
|
2721
Children's Place
PLCE
$53.8M
| $158K | ﹤0.01% |
+10,200
| New | +$90.3K |
|
2722
UNIFI
UFI
$126M
| $158K | ﹤0.01% |
21,432
| – | – |
|
2723
GCM Grosvenor
GCMG
$2.81B
| $157K | ﹤0.01% |
13,869
+190
| +1% | +$2.04K |
|
|
ENFN
2724
DELISTED
Enfusion, Inc.
ENFN
| $157K | ﹤0.01% |
16,508
+1,051
| +7% | +$9.07K |
|
|
EB
2725
DELISTED
Eventbrite
EB
| $156K | ﹤0.01% |
56,962
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.